DCAF6 and amyotrophic lateral sclerosis: Importantly, AAV-NRIP gene therapy in ALS mice rescued muscle atrophy, increased axon terminal innervation at the neuromuscular junction (NMJ), elevated NMJ number, and expanded α-motor neuron (α-MN) survival.